Christine Gebski is of REPLIGEN CORP. Currently has a direct ownership of 27,419 shares of RGEN, which is worth approximately $3.89 Million. The most recent transaction as insider was on May 14, 2024, when has been sold 334 shares (Common Stock) at a price of $163.34 per share, resulting in proceeds of $54,555. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.4K
0% 3M change
4.75% 12M change
Total Value Held $3.89 Million

Christine Gebski Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 14 2024
SELL
Payment of exercise price or tax liability
$54,555 $163.34 p/Share
334 Reduced 1.2%
27,419 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$75,547 $195.72 p/Share
386 Reduced 1.37%
27,753 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$25,412 $193.99 p/Share
131 Reduced 0.46%
28,139 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$88,839 $192.71 p/Share
461 Reduced 1.6%
28,270 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$85,730 $191.79 p/Share
447 Reduced 1.53%
28,731 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
391 Added 1.32%
29,178 Common Stock
Nov 10 2023
SELL
Open market or private sale
$557,328 $147.13 p/Share
3,788 Reduced 11.63%
28,787 Common Stock
May 16 2023
SELL
Payment of exercise price or tax liability
$51,446 $154.03 p/Share
334 Reduced 1.01%
32,575 Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$23,688 $188.0 p/Share
126 Reduced 0.38%
32,909 Common Stock
Mar 03 2023
BUY
Grant, award, or other acquisition
-
375 Added 1.12%
33,035 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$109,853 $174.37 p/Share
630 Reduced 2.11%
29,193 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
3,467 Added 9.6%
32,660 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$79,708 $173.28 p/Share
460 Reduced 1.52%
29,823 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$78,394 $173.44 p/Share
452 Reduced 1.47%
30,283 Common Stock
Aug 04 2022
SELL
Open market or private sale
$815,785 $243.01 p/Share
3,357 Reduced 9.85%
30,735 Common Stock
May 13 2022
SELL
Payment of exercise price or tax liability
$50,384 $150.4 p/Share
335 Reduced 0.97%
34,092 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$117,627 $196.7 p/Share
598 Reduced 1.71%
34,427 Common Stock
Feb 27 2022
SELL
Payment of exercise price or tax liability
$90,875 $196.7 p/Share
462 Reduced 1.3%
35,025 Common Stock
Feb 24 2022
SELL
Payment of exercise price or tax liability
$34,247 $189.21 p/Share
181 Reduced 0.51%
35,487 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
2,124 Added 5.62%
35,668 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$40,862 $182.42 p/Share
224 Reduced 0.66%
33,544 Common Stock
Feb 17 2022
BUY
Grant, award, or other acquisition
-
450 Added 1.32%
33,768 Common Stock
Sep 01 2021
SELL
Open market or private sale
$963,559 $285.33 p/Share
3,377 Reduced 9.2%
33,318 Common Stock
May 14 2021
SELL
Open market or private sale
$76,651 $172.25 p/Share
445 Reduced 1.2%
36,695 Common Stock
Mar 16 2021
SELL
Open market or private sale
$275,632 $196.88 p/Share
1,400 Reduced 3.63%
37,140 Common Stock
CG

Christine Gebski

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN